FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model

BACKGROUND: Malignant mesothelioma (MM) is a very aggressive type of cancer, with a dismal prognosis and inherent resistance to chemotherapeutics. Development and evaluation of new therapeutic approaches is highly needed. Immunosuppressant FTY720, approved for multiple sclerosis treatment, has recen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Szymiczek, Agata, Pastorino, Sandra, Larson, David, Tanji, Mika, Pellegrini, Laura, Xue, Jiaming, Li, Shuangjing, Giorgi, Carlotta, Pinton, Paolo, Takinishi, Yasutaka, Pass, Harvey I., Furuya, Hideki, Gaudino, Giovanni, Napolitano, Andrea, Carbone, Michele, Yang, Haining
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5353897/
https://ncbi.nlm.nih.gov/pubmed/28298211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-017-1158-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados